Kite Pharma, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Kite Pharma, Inc. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price of $31.77 per share as of 2017-06-30, per its 10-Q filed 2017-08-08.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice · last filed 2017-08-08
- 2017-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $31.77.
- 2017-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $31.02.
- 2016-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $28.57.
- 2016-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $24.98.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price |
|---|---|
| 2017-06-30 | $31.77 10-Q · filed 2017-08-08 |
| 2017-03-31 | $31.02 10-Q · filed 2017-05-08 |
| 2016-12-31 | $28.57 10-K · filed 2017-02-28 |
| 2016-09-30 | $24.98 10-Q · filed 2016-11-09 |
| 2016-06-30 | $22.27 10-Q · filed 2016-08-08 |
| 2016-03-31 | $18.38 10-Q · filed 2016-05-09 |
| 2015-12-31 | $12.30 10-K · filed 2016-02-29 |
| 2015-09-30 | $5.84 10-Q · filed 2015-11-12 |
| 2015-06-30 | $3.81 10-Q · filed 2015-08-10 |
| 2015-03-31 | $0.97 10-Q · filed 2015-05-15 |
| 2014-12-31 | $0.91 10-K · filed 2015-03-26 |
| 2014-09-30 | $0.85 10-Q · filed 2014-11-14 |
| 2014-06-30 | $0.86 10-Q · filed 2014-08-14 |